Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

about

Precision diabetes: learning from monogenic diabetes.Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date

P2860

Q33453490-FEA27F09-E6CB-4BF9-A356-D7166F86817D Q33858377-DDC4654D-7DCE-4EAE-AAB7-4FED747ED5C9 Q42373168-3BF3B3BA-AF1D-4763-9984-2F1475A46C71

P2860

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

Item

http://www.wikidata.org/entity/Q26751138

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@ast

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@en

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@nl

type

Item

label

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@ast

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@en

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@nl

prefLabel

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@ast

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@en

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@nl

P1476

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

@en

P2093

Kaixin Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Pharmacokinetics of Metformin

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets

A human transporter protein that mediates the final excretion step for toxic organic cations

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study

Novel compound heterozygous mutations in SLC5A2 are responsible for autosomal recessive renal glucosuria

Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2)

P304

17-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2446842

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/PGPM.S84854

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ewan Pearson

Adem Y Dawed

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27103840

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4827904

http://www.w3.org/2001/XMLSchema#string

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

about

P2860

P2860

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P50

P577

P698

P921

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P50

P577

P698

P921

P932